666
K. Manning et al. / Phytochemistry 72 (2011) 662–667
v/v antibiotic solution (Sigma). HT-29 and HCT-116 cells were
grown in McCoy’s 5a medium supplemented with 10% v/v fetal bo-
vine serum, 1% v/v nonessential amino acids, 2% v/v Hepes and 1%
v/v antibiotic solution. For each cell line, passage numbers between
22 and 35 were used. Cells were maintained at 37 °C in an incuba-
tor under a 5% CO2/95% air atmosphere at constant humidity and
maintained in the linear phase of growth.
Cytotoxicity studies were carried out using a MTS [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfenyl)-
2H-tetrazolium, inner salt] assay as described previously (Cory
et al., 1991). Briefly, test samples and a positive control, etoposide
3.8. 4-Benzoyl-3,5-dimethoxy-2-methyl-6,6-bis(3-methyl-2-
butenyl)cyclohexa-2,4-dienone
(1c): pale yellow oil; UV (MeOH) kmax (log
e
;
) 249 (4.30), 345
1H NMR (CDCl3)
(3.59) nm; IR (NaCl) mmax 1653, 1559, 1457 cmꢀ1
d: 7.95 (2H, d, J = 7.0 Hz, H-10/14), 7.56 (1H, dd, J = 7.0, 7.0 Hz, H-
12), 7.48 (2H, t, J = 7.0, 7.0 Hz, H-11/13), 4.93 (2H, t, J = 7.0 Hz, H-
16/21), 3.55 (3H, s, 5-OCH3), 3.48 (3H, s, 3-OCH3), 2.61 (4H, m,
H2-15/20), 1.79 (3H, s, H3-7), 1.68 (3H, s, H3-18/23), 1.58 (3H, s,
H3-19/24); 13C NMR (CDCl3) d: 202.0 (C-1), 195.4 (C-8), 169.5 (C-
3), 165.7 (C-5), 138.8 (C-9), 134.5 (C-17, C-22), 133.5 (C-12),
129.2 (C-10, C-14), 128.9 (C-11, C-13), 118.8 (C-16, C-21), 115.6
(C-2), 112.2 (C-4), 61.1 (5-OCH3), 59.6 (3-OCH3), 58.8 (C-6), 39.2
(C-15, C-20), 26.0 (C-18, C-23), 17.9 (C-19, C-24), 8.7 (C-7); HRE-
SIMS: m/z 409.2358 [M+H]+ (calcd for C26H33O4: 409.2379).
4 lg/mL (Sigma), were solubilized in DMSO by sonication. All sam-
ples were diluted with media to the desired treatment concentra-
tion and the final DMSO concentration per well did not exceed
0.5%. Control wells were also included on all plates. Following a
72 h drug-incubation period at 37 °C with serially diluted test com-
pounds, MTS, in combination with the electron coupling agent,
phenazine methosulfate, was added to the wells and cells were
incubated at 37 °C in a humidified incubator for 3 h. Absorbance
at 490 nm (OD490) was monitored with a spectrophotometer
(SpectraMax M2, Molecular Devices Corp., operated by SoftmaxPro
v.4.6 software, Sunnyvale, CA, USA) to obtain the number of surviv-
ing cells relative to control populations. The results are expressed
as the median cytotoxic concentrations (IC50 values) and were cal-
culated from six-point dose response curves using 4-fold serial
dilutions. Each point on the curve was tested in. Data are expressed
as means SE for three replications on each cell line.
3.9. 1,4,7-Trihydroxy-8-(3-methyl-2-butenyl)-9H-xanthen-9-one
(2): yellow solid; UV (MeOH) kmax (log e) 239 (3.35), 269 (3.34),
335 (1.72), 409 (1.81) nm; IR (KBr) mmax 3447, 1653, 1613, 1593,
1494 cmꢀ1; For 1H NMR and 13C NMR spectroscopic data, see Table
2; HRESIMS m/z 313.1069 [M+H]+ (calcd for C18H17O5: 313.1076).
3.10. 5,8,11-Trihydroxy-3,3-dimethyl-3H,12H-pyrano[3,2-a]xanthen-
12-one
(3): yellow solid; UV (MeOH) kmax (log e) 291 (3.61), 321 (3.59),
410 (3.22) nm; IR (KBr) mmax 3406, 1653, 1647, 1619, 1576, 1506,
1472, 1456 cmꢀ1; For 1H NMR and 13C NMR spectroscopic data,
see Table 2; HRESIMS m/z 327.0867 [M+H]+ (calcd for C18H15O6:
327.0869).
3.5. 2-Benzoyl-3,5-dihydroxy-6-methyl-4,4-bis(3-methyl-2-butenyl)-
cyclohexa-2,5-dienone
(1): white amorphous solid; UV (MeOH) kmax (log e) 249
Acknowledgements
(3.89) nm; IR (KBr) mmax 3424, 1653, 1588, 1560, 1508, 1493,
1448 cmꢀ1; For 1H NMR, 13C NMR and HMBC spectroscopic data,
see Table 1; HRESIMS: m/z 379.1919, [MꢀH]ꢀ (calcd for
This work was supported by a grant from Research Corporation
for Science Advancement (award #7252). We are grateful to Joe
Isaac for the collection of plant material. We thank Dr. Cliff Jones
at the CUNY Mass Spectrometry Facility at Hunter College for the
HRMS analyses.
C
24H27O4: 379.1909).
3.6. 2-Benzoyl-3,5-dimethoxy-6-methyl-4,4-bis(3-methyl-2-
butenyl)cyclohexa-2,5-dienone
References
(1a): pale yellow oil; UV (MeOH) kmax (log e) 250 (4.38) nm; IR
Avato, P., 2005. A survey on the Hypericum genus: secondary metabolites and
bioactivity. Stud. Nat. Prod. Chem. 30, 603–634.
Bumrungpert, A., Kalpravidh, R.W., Suksamrarn, S., Chaivisuthangkura, A.,
(NaCl) mmax 1674, 1656, 1607, 1458 cmꢀ1; For 1H NMR and 13C
NMR spectroscopic data, see Table 1; HRESIMS: m/z 409.2375,
[M+H]+ (calcd for C26H33O4: 409.2379).
Chitchumroonchokchai,
C.,
Failla,
M.L.,
2009.
Bioaccessibility,
biotransformation, and transport of alpha-mangostin from Garcinia
mangostana (Mangosteen) using simulated digestion and Caco-2 human
intestinal cells. Mol. Nutr. Food Res. 53 (Suppl. 1), S54–S61.
Chen, C.L., 1988. Characterization of lignin by oxidative degradation: use of gas
chromatography–mass spectrometry technique. Methods Enzymol. 161, 110–
136.
Ciochina, R., Grossman, R.B., Demirkiran, O., 2006. Polycyclic polyprenylated
acylphloroglucinols. Chem. Rev. 106, 3963–3986.
3.7. 2-Benzoyl-3,5-dimethoxy-4-methyl-6,6-bis(3-methyl-2-
butenyl)cyclohexa-2,4-dienone
Cory, A.H., Owen, T.C., Barltrop, J.A., Cory, J.G., 1991. Use of an aqueous soluble
tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun.
3, 207–212.
DeOliveira, C.M.A., Porto, A.M., Bittrich, V., Vencato, I., Marsaioli, A.J., 1996. Floral
resins of Clusia spp.: chemical composition and biological function. Tetrahedron
Lett. 37, 6427–6430.
Duan, Y.-H., Dai, Y., Wang, G.-H., Zhang, X., Chen, H.-F., Chen, J.-B., Yao, X.-S., Zhang,
X.-K., 2010. Bioactive xanthones from the stems of Cratoxylum formosum ssp.
pruniflorum. J. Nat. Prod. 73, 1283–1287.
El-Seedi, H.R., El-Barbary, M.A., El-Ghorab, D.M.J., Bohlin, L., Borg-Karlson, A.-K.,
Göransson, U., Verpoorte, R., 2010. Recent insights into the biosynthesis and
biological activities of natural xanthones. Curr. Med. Chem. 17, 854–901.
Ishiguro, K., Fukumoto, H., Nakajima, M., Isoi, K., 1993. Xanthones in cell suspension
cultures of Hypericum paturum. Phytochemistry 33, 839–840.
Minami, H., Takahashi, E., Fukuyama, Y., Kodama, M., Yoshizawa, T., Nakagawa, K.,
1995. Novel xanthones with superoxide scavenging activity from Garcinia
subelliptica. Chem. Pharm. Bull. 43, 347–349.
(1b): pale yellow oil; UV (MeOH) kmax (log
e
;
) 247 (4.53), 341
(4.08) nm; IR (NaCl)
m
max 1653, 1558, 1457 cmꢀ1
1H NMR (CDCl3)
d: 7.85 (2H, d, J = 7.0 Hz, H-9/13), 7.50 (1H, dd, J = 7.0, 7.0 Hz, H-
11), 7.39 (2H, dd, J = 7.0, 7.0 Hz, H-10/12), 4.91 (2H, t, J = 7.2 Hz,
H-16/21), 3.84 (3H, s, 5-OCH3), 3.68 (3H, s, 3-OCH3), 2.59 (2H, dd,
J = 14.0, 7.2 Hz, H-15/20), 2.43 (2H, dd, J = 14.0, 7.2 Hz, H-15/20),
1.95 (3H, s, H3-14), 1.68 (3H, s, H3-18/23), 1.53 (3H, s, H3-19/24);
13C NMR (CDCl3) d: 199.9 (C-1), 196.7 (C-7), 171.8 (C-3), 167.9
(C-5), 138.8 (C-8), 134.5 (C-17, C-22), 133.0 (C-11), 129.4 (C-9, C-
13), 128.5 (C-10, C-12), 118.8 (C-16, C-21), 115.6 (C-4), 114.5 (C-
2), 61.9 (5-OCH3), 60.7 (3-OCH3), 58.7 (C-6), 37.7 (C-15, C-20),
26.0 (C-18, C-23), 18.2 (C-19, C-24), 10.7 (C-14); HRESIMS: m/z
409.2368 [M+H]+ (calcd for C26H33O4: 409.2379).